The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2017

Filed:

May. 18, 2012
Applicants:

Matthew D. Shair, Lexington, MA (US);

Anthony William George Burgett, Norman, OK (US);

Inventors:

Matthew D. Shair, Lexington, MA (US);

Anthony William George Burgett, Norman, OK (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 15/24 (2006.01); C07J 17/00 (2006.01); C07J 41/00 (2006.01); C07J 43/00 (2006.01); C07J 51/00 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C07J 17/005 (2013.01); A61K 47/48384 (2013.01); A61K 47/48561 (2013.01); C07H 15/24 (2013.01); C07J 41/0055 (2013.01); C07J 43/003 (2013.01); C07J 51/00 (2013.01);
Abstract

Provided are a number of compounds structurally related to OSW-1, a natural compound that binds OSBPs. Also provided are pharmaceutical compositions comprising the OSW-1 analogs, as well as methods for use of these OSW-1 analogs, or pharmaceutically acceptable salts, enantiomers, or stereoisomers thereof in the treatment of atherosclerosis. Alzheimer's disease, and cancer, including p21-deficient cancer. Conjugates of OSW-1 analogs with monoclonal antibodies, including monoclonal antibodies targeted to cancer cells, are also provided. Also provided are pharmaceutical compositions comprising the conjugates, as well as methods for use of these conjugates, in the treatment of cancer, including p21-deficient cancer.


Find Patent Forward Citations

Loading…